Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15371981rdf:typepubmed:Citationlld:pubmed
pubmed-article:15371981lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C0043157lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C0079488lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C0162643lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C0220938lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C1332828lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:15371981lifeskim:mentionsumls-concept:C0205175lld:lifeskim
pubmed-article:15371981pubmed:issue3lld:pubmed
pubmed-article:15371981pubmed:dateCreated2004-9-16lld:pubmed
pubmed-article:15371981pubmed:abstractTextProton pump inhibitors, metabolized by the polymorphic enzyme cytochrome P450 (CYP) 2C19, are essential drugs for Helicobacter pylori eradication. It was reported that patients with CYP2C19 wild type in Asia had lower eradication rates. This study tests the hypothesis that CYP2C19 wild type ( wt/wt ) in white patients is also associated with a higher probability of treatment failure.lld:pubmed
pubmed-article:15371981pubmed:languageenglld:pubmed
pubmed-article:15371981pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15371981pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15371981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15371981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15371981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15371981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15371981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15371981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15371981pubmed:statusMEDLINElld:pubmed
pubmed-article:15371981pubmed:monthSeplld:pubmed
pubmed-article:15371981pubmed:issn0009-9236lld:pubmed
pubmed-article:15371981pubmed:authorpubmed-author:SchwabMatthia...lld:pubmed
pubmed-article:15371981pubmed:authorpubmed-author:TreiberGerhar...lld:pubmed
pubmed-article:15371981pubmed:authorpubmed-author:KlotzUlrichUlld:pubmed
pubmed-article:15371981pubmed:authorpubmed-author:SchaeffelerEl...lld:pubmed
pubmed-article:15371981pubmed:issnTypePrintlld:pubmed
pubmed-article:15371981pubmed:volume76lld:pubmed
pubmed-article:15371981pubmed:ownerNLMlld:pubmed
pubmed-article:15371981pubmed:authorsCompleteYlld:pubmed
pubmed-article:15371981pubmed:pagination201-9lld:pubmed
pubmed-article:15371981pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:meshHeadingpubmed-meshheading:15371981...lld:pubmed
pubmed-article:15371981pubmed:year2004lld:pubmed
pubmed-article:15371981pubmed:articleTitleCYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori.lld:pubmed
pubmed-article:15371981pubmed:affiliationDr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, D-70376 Stuttgart, Germany. matthias.schwab@ikp.stuttgart.delld:pubmed
pubmed-article:15371981pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15371981pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1557entrezgene:pubmedpubmed-article:15371981lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15371981lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15371981lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15371981lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15371981lld:pubmed